The FDA has cleared home use of a device that helps people with spinal cord injuries regain mobility and functioning.

Analysts remain high on Boston Scientific after a visit to the company's Marlborough, Massachusetts headquarters.

Global Neuromodulation Devices Market OverviewThe global neuromodulation devices market is poised to witness substantial ...

Boston Scientific rides on strong neuromodulation momentum as sales climb, new technologies gain traction and recent acquisitions expand its pain-treatment reach.

ONWARD Medical N.V. (Euronext: ONWD - US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore ...

Shares of Boston Scientific BSX have climbed 7% over the past 30 days, extending their positive year-to-date momentum. The stock’s performance has outpaced its industry’s 0.9% gains, the broader ...

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION ...

Request To Download Free Sample of This Strategic Report @ Market Overview In 2018, the global neurostimulation devices market exhibited a valuation of $4,387.5 million, marking the inception of a ...

"Cala is trailblazing a new era in non-invasive neuromodulation for hand tremor, broadening access and awareness for patients," said Deanna Harshbarger, Chief Executive Officer of Cala Health. "As ...

Onward Medical N.V. ( OTC:ONWRF) Q3 2025 Earnings Call November 24, 2025 8:00 AM EST ...

Texas voters' approval of Proposition 14 during Tuesday’s election is a boon for research into dementia, Alzheimer’s, and ...

Onward Medical announced today that it received FDA 510(k) clearance to expand the ARC-EX system's indication for home use.